RxDoctor Payments Data

Evan Schreyer, MD

Cardiovascular Disease · Hartford, CTNPI 1861841157

Payments from drug & device makers

$1,773in general payments, 2019–2025

Across 51 payments — averaging $34.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$325
  • Medtronic$283
  • E.r. Squibb & Sons, L.L.C.$248
  • Astellas Pharma US Inc$189
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$153
  • Boston Scientific$116
  • plus $460 from 10 others

What the payments were for

  • Food & beverage$1,36677%
  • Education$40723%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,773 in reported general payments places this provider in the 50th percentile of 415 cardiovascular disease providers in Connecticut.

See all cardiovascular disease providers in Connecticut

Medicare billing

Part B allowed, 2024
$66,255
Medicare patients
672
Services billed
1,009

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →